venturevaluation.ch
Global Valuation Services | Venture Valuation
http://www.venturevaluation.ch/en
How much is your company worth? Understanding the complexities on how a company valuation is undertaken can make the difference between failure and success in your negotiations. We offer expert advice on how you can derive a valuation for your business. Click here for more information. We value and prepare companies for negotiations who are seeking capital or for Merger and Acquisition (M and A) deals ». We calculate the value of products and patents using the rNPV model ».
venturevaluation.ch
About us | Venture Valuation
http://www.venturevaluation.ch/en/about-us
Venture Valuation was founded in 1999 based on research work by the founder and CEO, Dr. Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). The company has remained true to its mission: the independent assessment and valuation of companies, products and patents. In addition to our assessment services in Life Sciences, in 2003 we established the " Swiss Life Sciences Database. At Venture Valuation, we always place experienced internal consu...
venturevaluation.ch
Partner identification for Biotech, Pharma and Medtech | Venture Valuation
http://www.venturevaluation.ch/en/services/partnering/partner-identification
Partner identification for Biotech, Pharma and Medtech. Forming partnerships between companies is a typical strategic move in the life sciences industry. However finding the right partner for your organization can mean the difference between failure and success. Regardless of whether you are looking for collaboration on research and development (R&D) or licensing deals, the identification process can be a very complex task. Step II: Creating detailed company profiles for selected companies from phase I.
venturevaluation.ch
Product Valuation | Venture Valuation
http://www.venturevaluation.ch/en/services/valuation/product-valuation
A detailed assessment of your technology and market. The calculated, risk adjusted net present value (rNPV) of your IP or product. A scenario and sensitivity analysis including various possible deal structures. A forecast of the future value of your IP or product following successful completion of key development milestones. A list of benchmark deals from our Biotechgate database. For more information on this topic:. Get to Know Us.
venturevaluation.ch
Team | Venture Valuation
http://www.venturevaluation.ch/en/about-us/team
PhD, lic. oec. HSG. Lic rer. pol. (M.A.), MAS Business IT. Susanne E. Acklin. Senior Advisor and VP Life Sciences. Senior Advisor and VP Life Sciences. Business Analyst and Business Development USA. Online and Marketing Manager. Ronald E. Layden. Senior Advisor and VP Life Sciences. Senior Business Development Executive. Barbara joined Venture Valuation in early 2014. She has vast experience in multiple roles for a number of life science companies. Barbara is now a part of the Biotechgate busines...Wim i...
venturevaluation.ch
Portfolio Valuation | Venture Valuation
http://www.venturevaluation.ch/en/services/valuation/portfolio-valuation
Investment analysis and monitoring to fund managers, limited partners, shareholders, beneficiaries or holding companies is a key part for maintaining a successful investment portfolio. All stakeholders expect frequent reports on the development of portfolio companies, often including periodic assessments and calculations of net asset value (NAV). We can perform the following ongoing valuation and reporting services for you:. Quarterly / annual reviews (Valuation Reports). Our valuation process follows th...
venturevaluation.ch
Valuation Workshops | Venture Valuation
http://www.venturevaluation.ch/en/services/workshops/valuation-workshops
Are you interested in topics such as business or product valuation? We regularly conduct workshop settings (Valuation workshops) in small groups with our partner CELforpharma. If required, we can also offer in-house courses which can be tailored to your particular needs. The course content is interactive and participants can actively participate in small class sizes. Our valuation workshops can help you develop an understanding of the following:. What determines the value of a company. More on this topic:.
venturevaluation.ch
References | Venture Valuation
http://www.venturevaluation.ch/en/references/clients
We’ve served over 400 satisfied customers. Our clients include investors (about 45%) and companies (about 55%). Have a look at our non-confidential list of investors and companies to get an idea of what we can do for you. Biotech investment company of BSI SA. Celtic Pharma Holdings II L.P. Private equity fund (target USD 750m) with investments in the pharmaceutical and biotechnology sectors. European Investment Bank (EIB). European Union's financing institution. Biotech focused private investor. Medtech ...
venturevaluation.ch
Global Valuation Services | Venture Valuation
http://www.venturevaluation.ch/de
Wieviel ist ihr Unternehmen wert? Die richtige Bewertung entscheidet in Verhandlungen über Erfolg oder Niederlage. Lassen Sie sich von uns beraten. Klicken Sie hier für mehr informationen. Wir bewerten Unternehmen für Investitionsverhandlungen oder bei Zusammenschlüssen und Akquisitionen (M&A) ». Wir berechnen den Wert von Produkten und Patenten nach dem rNPV Modell ». Wir unterstützen Sie beim Reporting und Monitoring von Investitions-Portfolios ». Partnersuche Biotech / Medtech.
venturevaluation.ch
Company Valuation | Venture Valuation
http://www.venturevaluation.ch/en/services/valuation/company-valuation
Company valuation is a critical part of any business transaction and will be required for many reasons. Regardless of whether you seek to complete an investment, an Initial Public Offering (IPO) or a Merger and Acquisition (M&A), the valuation forms an integral part of negotiations and can ultimately determine the success of a given transaction. Discounted cash flow (DCF) method. Risk-adjusted Net Present Value (rNPV) method. Decision Tree valuation / Real options method. Sum of parts valuation.
